L Capital Partners

Total investments

23

Average round size

14M

Portfolio companies

14

Rounds per year

1.10

Lead investments

5

Follow on index

0.39

Exits

4

Stages of investment
Early Stage VentureLate Stage Venture
Areas of investment
BiotechnologySupply Chain ManagementSoftwareHealth CareManufacturingMedicalFashionPharmaceuticalTherapeuticsBiopharma

Summary

The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the New York.

Among the most popular portfolio startups of the fund, we may highlight Intrapace, CeNeRx BioPharma, WiSpry. The fund has exact preference in a number of founders of portfolio startups. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Supply Chain Management, Medical. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the L Capital Partners, startups are often financed by Johnson & Johnson Development Corporation, Prism Venture Management, Oak Investment Partners. The meaningful sponsors for the fund in investment in the same round are Oak Investment Partners, Johnson & Johnson Development Corporation, HealthCap. In the next rounds fund is usually obtained by Quaker BioVentures, Oak Investment Partners, HealthCap.

The common things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this L Capital Partners works on 15 percentage points less the average amount of lead investments. Considering the real fund results, this VC is 7 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2008. The higher amount of exits for fund were in 2015.

Show more

Investments analytics

Analytics

Total investments
23
Lead investments
5
Exits
4
Rounds per year
1.10
Follow on index
0.39
Investments by industry
  • Biotechnology (12)
  • Health Care (8)
  • Manufacturing (7)
  • Medical (6)
  • Therapeutics (4)
  • Show 24 more
Investments by region
  • United States (21)
  • Spain (1)
  • Italy (1)
Peak activity year
2008

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
20
Avg. valuation at time of investment
28M
Group Appearance index
0.87
Avg. company exit year
9
Avg. multiplicator
5.11

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
beModel 01 Dec 2009 Fashion, Photography Seed 75K United States, Colorado, Denver
Eleme Medical 16 Jul 2008 Biotechnology, Health Care, Pharmaceutical Late Stage Venture 18M United States, New Hampshire, Merrimack
Kaiam 07 Jun 2011 Wholesale, Retail, Retail Technology, Manufacturing, Telecommunications, Optical Communication Early Stage Venture 5M Sindh, Karachi, Pakistan
WiSpry 17 Oct 2006 Infrastructure, Mobile, Manufacturing, Semiconductor, Electronics, Wireless Early Stage Venture 13M United States, California, Irvine

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.